Loading clinical trials...
Loading clinical trials...
To evaluate the efficacy and safety of second uterine curettage in patients with low-risk non-metastatic GTN.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Brigham and Women's Hospital
Collaborators
NCT05139095 · Gestational Trophoblastic Neoplasia
NCT06169644 · Gestational Trophoblastic Neoplasia
NCT05635344 · Gestational Trophoblastic Disease, Gestational Trophoblastic Neoplasia, and more
NCT03135769 · Gestational Trophoblastic Neoplasias (GTN)
NCT06900699 · Gestational Trophoblastic Neoplasias (GTN)
Paulista State University UNESP
Botucatu
Campinas State University UNICAMP
Campinas
University of Caxias do Sul
Caxias do Sul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions